CoChat

Insulin Resistance and Aging: A Cause or a Protective Response?

Barzilai, N., Ferrucci, L. · 2012 · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
Cited by 94

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

If you are bitter at heart, sugar in the mouth will not help you. Traditional Yiddish Proverb Metabolic syndrome consists of metabolic defects associated with increased risks of type 2 diabetes mellitus, cardiovascular diseases, prothrombotic and inflammatory states, and possibly Alzheimer’s disease, cancer, and reduced longevity (1). The metabolic syndrome of aging was originally called insulin resistance syndrome, pointing to insulin resistance as the key factor. In older persons, age-related rise of visceral adiposity and accumulation of senescent cells with inflammatory phenotype result in high blood levels of proinflammatory cytokines that likely interfere with insulin signaling (2). The resulting insulin resistance is characterized by dysfunctional IRS–PI3–kinase/Akt pathway that causes impaired glucose uptake in muscle and fat cells, reduced glycogen synthesis/storage in the liver, and failure to suppress hepatic glucose production. Insulin resistance contribute to increase cardiovascular morbidity in part through impairments in lipid uptake and storage of circulating lipids leading to increased plasma levels of very low-density lipoprotein (proatherogenic apoB-containing/triglyceride-rich lipoproteins),which is typical to this syndrome (1). Because of its high prevalence and strong association with many adverse outcomes, insulin resistance is often considered having a causal role in many adverse aging phenotypes and age-related conditions. In fact, it has even been suggested that counteracting insulin resistance could be an effective “antiaging” intervention. This view is in open contrast with widely accepted notion that a downregulation (by genetic modulation) of the insulin signaling pathway in invertebrates is associated with exceptional longevity (3). In fact, over the last decade, the search for the mechanisms by which decline in insulin action leads to longevity has been the most frequent and productive research topics in the biology of aging. The first explanation that comes into mind for this paradox is that mammalian physiology is several orders more complex than invertebrate and the role of insulin signaling has evolved to encompass regulatory functions beyond carbohydrate handling. Hence, the relationship of insulin signaling dysregulation and longevity is quite different across species. Genetic modifications that downregulate the entire insulin signaling may have different effects than insulin resistance where only some specific insulin actions are impaired. There is no doubt that the overproduction of insulin from the pancreas partially and temporarily counteracts the effects of insulin resistance on glucose and lipids. However, high insulin levels also result in activation of the mitogen-activated protein kinase pathways, which is not affected by insulin resistance and stimulates cellular migration, vascular smooth muscle cell proliferation, and a prothrombotic state. Thus, the compensatory hyperinsulinemia can progressively shift the balance of insulin signaling toward a mitogenic state leading to accelerated atherosclerosis. Indeed, euglycemic clamp studies in caloric-restricted animals (4–6) revealed enhanced insulin sensitivity compared with normally fed controls (7–9). Surgical removal of visceral fat in aging rodents restored insulin sensitivity and prolonged life span (10). Administration of resveratrol, a compound that activates sirtuin (sirtuin molecules have been associated with longevity), to aging mice on a high-calorie diet increases insulin sensitivity and normalizes their life span (11). However, there is also evidence that insulin sensitivity and longevity may lie on different causal pathways that are not necessarily interconnected. Signaling downregulation of the target for rapamycin and more recently of its mammalian equivalent extends life spans in multiple species, by multiple mechanisms such as enhanced autophagy and decreased mitochondrial production of reactive oxygen species. Interestingly, reduction of mTOR signaling is associated with decreased insulin sensitivity (12). In this special issue of Journals of Gerontology: Biological and Medical Sciences (13), Nelson and his colleagues present data on insulin sensitivity in three rodent models that were primarily studied for longevity. Although the insulin-resistant model (IRKO+/−) lived longer, two insulin-sensitive models (PTP-1B−/− or PCG-1αTG) tended to have shorter middle or maximal life span. These data suggest that in mammals, enhanced insulin sensitivity is neither a necessary nor a sufficient step toward increased longevity. Table 1 includes other examples where longevity and insulin sensitivity were separated (14–21). Such a paradoxical window of the relationship between insulin signaling and longevity across species clearly casts serious doubts on whether downregulating the insulin signaling may have beneficial effects in humans. Haven’t we always been told that insulin resistance is “evil” and should b

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/gerona/gls145

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 94

Metadata

Authors
Barzilai, N., & Ferrucci, L.
Venue
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
Published
2012-08-02
Volume
67
Issue
12
Pages
1329-1331
ISSN
  • 1079-5006 (ISSN-L)
  • 1758-535X
OpenAlex
W2160382059
Cited by
94
References
8
FWCI
1.26
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insulin Resistance and Aging: A Cause or a Protective Response? https://app.cochat.ai/papers/10.1093/gerona/gls145
The paper
Barzilai, N., & Ferrucci, L. (2012). Insulin Resistance and Aging: A Cause or a Protective Response? The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/gls145

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.